Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.003 Å; disorder in main residue; R factor = 0.046; wR factor = 0.141; data-to-parameter ratio = 19.8.
In the title compound, C 31 H 32 N 2 O 6 ÁH 2 O, the pyrrolidine ring adopts an envelope conformation. The ethyl C atoms of the ethoxycabonyl group are disordered over two positions with occupancies of ca 0.80 and 0.20. Intramolecular N-HÁ Á ÁO hydrogen bonds form S(5) and S(6) ring motifs. Molecules are linked into a three-dimensional framework by O-HÁ Á ÁO, N-HÁ Á ÁO and C-HÁ Á ÁO hydrogen bonds, and by C-HÁ Á Á interactions.
Related literature
For related literature, see: Amalraj et al. (2003) ; Beddoes et al. (1986) ; Cordell (1981) ; Suzuki et al. (1994) . For hydrogenbond motifs, see: Bernstein et al. (1995) . For ring conformational analysis, see : Cremer & Pople (1975); Nardelli (1983) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
D-HÁ
Data collection: APEX2 (Bruker, 2004 ); cell refinement: APEX2; data reduction: SAINT (Bruker, 2004 ); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997) ; software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2003) .
MS thanks Dr Babu Varghese, SAIF, IIT-Madras, India, for his help with the data collection.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: CI2651).
Ethyl
4'-ethenyl-2'-oxo-4-phenyl-2-(3,4,5-trimethoxyphenyl)spiro[pyrrolidine-3,3'-indoline]-5-carboxylate monohydrate M. Sathyanarayanan, P. Ramesh, R. Murugan, S. S. Narayanan and M. N. Ponnuswamy Comment Substituted pyrrolidine compounds possess antimicrobial and antifungal activity against various pathogens (Amalraj et al., 2003) . Several optically active pyrrolidine compounds are used as intermediates in controlled asymmetric synthesis (Suzuki et al., 1994) . The spiro-indole-pyrrolidine ring system is a frequently encountered structural motif in many biologically important and pharmacologically relevant alkaloids, e.g. vincrinstine, vinblastine and spirotypostatins (Cordell, 1981) . Against this background and to ascertain the detailed information on its molecular conformation, the structure determination of the title compound has been carried out.
The pyrrolidine ring (N1-C5) adopts an envelope conformation, with puckering (Cremer & Pople, 1975) and asymmetry (Nardelli, 1983) parameters q 2 = 0.416 (2) Å, φ = 137.5 (2)° and Δ s (C5) = 2.8 (2)°. The indoline ring system is planar and the keto atom O3 lies on the plane. The sum of angles at atom N1 of the pyrrolidine ring (323.3°) is in accordance with sp 3 hybridization (Beddoes et al., 1986) . The ethoxycarbonyl group is in an extended conformation as evidenced by torsion angles C2-C6-O2-C7 of -170.3 (3)° and C6-O2-C7-C8 of 170.3 (3)°.
Intramolecular N1-H1···O1 and N1-H1···O3 hydrogen bonds generate S(5) and S(6) ring motifs (Bernstein et al. 1995) , respectively. The crystal packing is stabilized by O-H···O, O-H···N, N-H···O and C-H···O hydrogen bonds, and C-H···π intermolecular interactions (Table 1) which link the molecules into a three-dimensional framework. 
Refinement
The ethyl C atoms of the ethoxycarbonyl group are disordered over two positions (C7/C7A and C8/C8A) with refined occupancies of 0.797 (8) and 0.203 (8). The corresponding bond distances involving the disordered atoms were restrained to 1.54 (5) Å, and also the U ij parameters of atoms C7, C7A, C8 and C8A were restrained to an approximate isotropic behaviour.
The O-and N-bound H atoms were located in a difference map and refined with O-H and H···H distances restrained to 0.84 (1) and 1.37 (1) Å, respectively. The remaining H atoms were positioned geometrically (C-H = 0.93-0.98 Å) and allowed to ride on their parent atoms, with U iso (H) = 1.2-1.5(methyl) U eq (C). A search for solvent-accessible voids in the crystal structure using PLATON showed a potential solvent volume of 2189.3 Å 3 and subsequent application of SQUEEZE procedures showed three relevant voids each with a solvent-accessible volume of 730 Å 3 . However, this procedure showed supplementary materials sup-2 no electrons in the voids. This indicates that the crystal lost nearly all of its solvent of crystallization by the time it was used for data collection, without collapse of the structure.
Figures Fig. 1 . The molecular structure of the title compound, showing 30% probability displacement ellipsoids. Both disorder components are shown.
Crystal data (7) 0.0699 (9) 0.0813 (10) 0.0354 (7) 0.0131 (7) 0.0068 (7) O2 0.0454 (7) 0.0612 (8) 0.0703 (9) 0.0201 (6) 0.0217 (6) 0.0187 (7) O3 0.0417 (6) 0.0510 (7) 0.0404 (6) 0.0303 (5) 0.0012 (5) 0.0064 (5) O5 0.0351 (6) 0.0546 (7) 0.0608 (7) 0.0231 (6) 0.0113 (5) 0.0135 (6) O6 0.0465 (7) 0.0408 (6) 0.0553 (7) (7) 0.0181 (7) 0.0010 (6) 0.0039 (6) C18 0.0512 (10) 0.0565 (10) 0.0331 (7) 0.0271 (8) 0.0021 (7) 0.0032 (7) C19 0.0534 (10) 0.0622 (11) 0.0385 (8) 0.0304 (9) 0.0083 (7) −0.0018 (7) C20 0.0424 (9) 0.0494 (9) 0.0472 (9) 0.0268 (8) 0.0073 (7) 0.0005 (7) C21 0.0333 (7) 0.0380 (8) 0.0387 (7) 0.0180 (6) 0.0038 (6) 0.0037 (6) C22 0.0305 (7) 0.0347 (7) 0.0322 (7) 0.0154 (6) 0.0020 (5) Symmetry codes: (i) y+1/3, −x+y+2/3, −z+2/3; (ii) −x+1, −y, −z+1; (iii) −y+1/3, x−y−1/3, z−1/3; (iv) −x+y+2/3, −x+1/3, z+1/3.
supplementary materials sup-10 Fig. 1 
